The predictive significance of anti-RO-52 antibody in patients with interstitial pneumonia after treatment of malignant tumors
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
De Gruyter
2025-08-01
|
| Series: | Open Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1515/med-2025-1190 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849390723927900160 |
|---|---|
| author | Li Zongyu Yang Li Zhu Yan Ye Shengli Fang Xin Xu Qiuping |
| author_facet | Li Zongyu Yang Li Zhu Yan Ye Shengli Fang Xin Xu Qiuping |
| author_sort | Li Zongyu |
| collection | DOAJ |
| format | Article |
| id | doaj-art-9a7b502387ff4ee1beadf4d006c6364c |
| institution | Kabale University |
| issn | 2391-5463 |
| language | English |
| publishDate | 2025-08-01 |
| publisher | De Gruyter |
| record_format | Article |
| series | Open Medicine |
| spelling | doaj-art-9a7b502387ff4ee1beadf4d006c6364c2025-08-20T03:41:22ZengDe GruyterOpen Medicine2391-54632025-08-0120118374610.1515/med-2025-1190The predictive significance of anti-RO-52 antibody in patients with interstitial pneumonia after treatment of malignant tumorsLi Zongyu0Yang Li1Zhu Yan2Ye Shengli3Fang Xin4Xu Qiuping5Department of Respiratory and Critical Care Medicine, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, 330100, ChinaDepartment of Respiratory and Critical Care Medicine, The Fourth Affiliated Hospital ZheJiang University School of Medicine, Hangzhou, 322000, ChinaDepartment of Respiratory and Critical Care Medicine, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, 330100, ChinaDepartment of Radiology, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, 330100, ChinaDepartment of Respiratory and Critical Care Medicine, Shulan (Hangzhou) Hospital Affiliated to Zhejiang Shuren University Shulan International Medical College, Hangzhou, 330100, ChinaDepartment of Critical Care Medicine, ZheJiang University School of Medicine Sir Run Run Shaw Hospital, No. 3 Qingchun East Road, Shangcheng District, Hangzhou, 310020, Chinahttps://doi.org/10.1515/med-2025-1190malignant tumorsanti-ro-52interstitial lung diseasepredictive |
| spellingShingle | Li Zongyu Yang Li Zhu Yan Ye Shengli Fang Xin Xu Qiuping The predictive significance of anti-RO-52 antibody in patients with interstitial pneumonia after treatment of malignant tumors Open Medicine malignant tumors anti-ro-52 interstitial lung disease predictive |
| title | The predictive significance of anti-RO-52 antibody in patients with interstitial pneumonia after treatment of malignant tumors |
| title_full | The predictive significance of anti-RO-52 antibody in patients with interstitial pneumonia after treatment of malignant tumors |
| title_fullStr | The predictive significance of anti-RO-52 antibody in patients with interstitial pneumonia after treatment of malignant tumors |
| title_full_unstemmed | The predictive significance of anti-RO-52 antibody in patients with interstitial pneumonia after treatment of malignant tumors |
| title_short | The predictive significance of anti-RO-52 antibody in patients with interstitial pneumonia after treatment of malignant tumors |
| title_sort | predictive significance of anti ro 52 antibody in patients with interstitial pneumonia after treatment of malignant tumors |
| topic | malignant tumors anti-ro-52 interstitial lung disease predictive |
| url | https://doi.org/10.1515/med-2025-1190 |
| work_keys_str_mv | AT lizongyu thepredictivesignificanceofantiro52antibodyinpatientswithinterstitialpneumoniaaftertreatmentofmalignanttumors AT yangli thepredictivesignificanceofantiro52antibodyinpatientswithinterstitialpneumoniaaftertreatmentofmalignanttumors AT zhuyan thepredictivesignificanceofantiro52antibodyinpatientswithinterstitialpneumoniaaftertreatmentofmalignanttumors AT yeshengli thepredictivesignificanceofantiro52antibodyinpatientswithinterstitialpneumoniaaftertreatmentofmalignanttumors AT fangxin thepredictivesignificanceofantiro52antibodyinpatientswithinterstitialpneumoniaaftertreatmentofmalignanttumors AT xuqiuping thepredictivesignificanceofantiro52antibodyinpatientswithinterstitialpneumoniaaftertreatmentofmalignanttumors AT lizongyu predictivesignificanceofantiro52antibodyinpatientswithinterstitialpneumoniaaftertreatmentofmalignanttumors AT yangli predictivesignificanceofantiro52antibodyinpatientswithinterstitialpneumoniaaftertreatmentofmalignanttumors AT zhuyan predictivesignificanceofantiro52antibodyinpatientswithinterstitialpneumoniaaftertreatmentofmalignanttumors AT yeshengli predictivesignificanceofantiro52antibodyinpatientswithinterstitialpneumoniaaftertreatmentofmalignanttumors AT fangxin predictivesignificanceofantiro52antibodyinpatientswithinterstitialpneumoniaaftertreatmentofmalignanttumors AT xuqiuping predictivesignificanceofantiro52antibodyinpatientswithinterstitialpneumoniaaftertreatmentofmalignanttumors |